Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hisamitsu Forms Genofunctionfor Genome-related Business
April 23, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 23, 2001
- Keidanren, Nikkeiren to Discuss Healthcare System for Elderly
April 23, 2001
- WORLD NEWS IN BRIEF
April 23, 2001
- BUSINESS NEWS IN BRIEF -1-
April 23, 2001
- Hac Kimisawa to Open Record-high Number of New Stores
April 23, 2001
- BUSINESS NEWS IN BRIEF -2-
April 23, 2001
- Ain Pharmaciez, Nice Drug to Jointly Operate Large Dispensing Pharmacies in Tokai
April 23, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
April 23, 2001
- DIAGNOSTICS NEWS IN BRIEF
April 23, 2001
- NEW PRODUCTS NEWS IN BRIEF
April 23, 2001
- Kureha, Sankyo Tie Up for Joint Development of CXCR4 Blocker
April 23, 2001
- Patients"Success Rate Increases to Record High in 2000: Malpractice Lawsuits
April 23, 2001
- Market Share of Generics Should Be Considered in Pricing of Long-listed Drugs: JMA
April 23, 2001
- LDP's Commission Lists 4 Points of Discussion for NHI Pricing Reform
April 23, 2001
- Mr MRto Enable Physicians to Easily Access Information: Mr Tanimura of So-net M3
April 23, 2001
- REGULATORY NEWS IN BRIEF
April 23, 2001
- MEDICAL DEVICE NEWS IN BRIEF
April 23, 2001
- Marketing of Half-strength Preparations of Digoxin Expected
April 23, 2001
- Fujisawa, ORIX Capital Establishes New Investment Fund
April 23, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…